John F. Chin
Directeur/Membre du Conseil chez ANTENGENE CORPORATION LIMITED
Fortune : 182 385 $ au 30/06/2024
Postes actifs de John F. Chin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ANTENGENE CORPORATION LIMITED | Directeur/Membre du Conseil | 18/08/2020 | - |
| Corporate Officer/Principal | 18/08/2020 | - | |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/10/1998 | - |
Antengene Corporation Co., Ltd.
 Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Directeur/Membre du Conseil | - | - |
| Corporate Officer/Principal | - | - |
Historique de carrière de John F. Chin
Anciens postes connus de John F. Chin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CELGENE | Corporate Officer/Principal | 01/01/2005 | 01/01/2020 |
Formation de John F. Chin
| University of Arizona | Undergraduate Degree |
| Pepperdine University | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 5 |
| Chine | 3 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ANTENGENE CORPORATION LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Antengene Corporation Co., Ltd.
Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Health Technology |
- Bourse
- Insiders
- John F. Chin
- Expérience
